tiprankstipranks
pc:cre3h

CREATE Medicines

CREATE Medicines is a biotechnology company developing in vivo CAR therapies focused on both autoimmune diseases and oncology. The company is advancing repeat-dose capable CD19-targeted in vivo CAR-T therapies and dual CAR programs such as CD19 x BCMA, leveraging its platform to enable targeted, repeat-administered cellular reprogramming.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$122M
Total Amount Raised$122M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$122M
Latest Funding Amount$122M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
May 14, 2026
Series B
$122.00M

Investors

Investor Name
Funding Round

Related News and Analysis